{"title":"Tinea Capitis Caused by Trichophyton tonsurans That Responded to Fosravuconazole.","authors":"Ayaka Miyata, Utako Kimura, Hiromitsu Noguchi, Masataro Hiruma, Rui Kano, Yasushi Suga","doi":"10.3314/mmj.24-00032","DOIUrl":null,"url":null,"abstract":"<p><p>We herein report the first case of tinea capitis caused by Trichophyton tonsurans that responded to fosravuconazole (F-RVCZ). Clinical improvement was achieved within six weeks after the start of F-RVCZ therapy, and the hairbrush culture test was negative. After treatment discontinuation, no relapse of symptoms was observed, and subsequent hairbrush cultures remained negative. F-RVCZ has been suggested as a rapidly acting and effective therapeutic agent for tinea capitis caused by this infection. Treatment of tinea capitis requires oral antifungal therapy; however, side effects associated with long-term administration sometimes occur. Oral treatment with F-RVCZ was found to be effective and had the advantage of relatively few side effects.</p>","PeriodicalId":520314,"journal":{"name":"Medical mycology journal","volume":"66 2","pages":"51-54"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3314/mmj.24-00032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We herein report the first case of tinea capitis caused by Trichophyton tonsurans that responded to fosravuconazole (F-RVCZ). Clinical improvement was achieved within six weeks after the start of F-RVCZ therapy, and the hairbrush culture test was negative. After treatment discontinuation, no relapse of symptoms was observed, and subsequent hairbrush cultures remained negative. F-RVCZ has been suggested as a rapidly acting and effective therapeutic agent for tinea capitis caused by this infection. Treatment of tinea capitis requires oral antifungal therapy; however, side effects associated with long-term administration sometimes occur. Oral treatment with F-RVCZ was found to be effective and had the advantage of relatively few side effects.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
